<DOC>
	<DOCNO>NCT01367054</DOCNO>
	<brief_summary>The objective evaluate , healthy volunteer , bioavailability two product contain metformine 500 mg determine bioequivalent identify occurrence adverse event .</brief_summary>
	<brief_title>Adverse Events Pharmaceutical Bioequivalence Study Two Formulations Metformine Hydrochloride 500 mg</brief_title>
	<detailed_description>OBJECTIVE : To evaluate , healthy volunteer , bioavailability two product contain metformine 500 mg determine bioequivalent identify occurrence adverse event . MATERIAL AND METHODS : The study approve research Ethics Committee twenty-eight volunteer sign select IC . An open , randomize , crossover study two period confinement interval seven day perform . Twenty ( 20 ) blood collection perform 30 minute 36 hour drug administration . Plasma sample analyze liquid chromatography mass spectrometry ( LC-MS/MS ) . Statistical analysis conduct base pharmacokinetic parameter : maximum concentration ( Cmax ) area curve ( AUC 0-te AUC 0-inf ) . Analysis variance ( ANOVA ) model appropriate employ two period cross logarithmically transform data .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Within 10 % ideal body weight Age 18 50 year Healthy condition Ability understand write informed consent Pregnancy Smokers Alcohol drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Metformine</keyword>
	<keyword>adverse event</keyword>
	<keyword>bioequivalence</keyword>
</DOC>